Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correlation of Spleen Size and Hematoma Volume With Clinical Course and 45- Day Mortality in Emergency Patients With Hemorrhagic Stroke

NCT07132996 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.

NCT NCT07132996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07132996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correlation of Spleen Size and Hematoma Volume With Clinical Course and 45- Day Mortality in Emergency Patients With Hemorrhagic Stroke
Lead sponsor
Ankara City Hospital Bilkent
Phase
Observational
Overall status
Completed
Start date
March 15, 2024
Completion date
October 30, 2024
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute brain injury, hemorrhagic stroke, intracerebral, intracerebral hemorrhage (ich), neurocritical care, ultrasound